Drug eruptions in children

Current Problems in Pediatrics

Volumn 31, Issue 7, 2001, Pages 207-234

  Shin, Helen T ^a   Chang, Mary Wu ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ATROPINE; BENZODIAZEPINE; CEPHALOSPORIN; CHLORAL HYDRATE; COTRIMOXAZOLE; COUMARIN; CROMOGLYCATE DISODIUM; DIGITALIS; DIPHENHYDRAMINE; LAXATIVE; LOCAL ANESTHETIC AGENT; MINERAL; MUSCLE RELAXANT AGENT; NITRATE; NYSTATIN; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PENICILLIN G; PROMETHAZINE; PROPRANOLOL; SPIRONOLACTONE; SULFONAMIDE; THEOPHYLLINE; THYROID HORMONE; UNINDEXED DRUG; VITAMIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILD HEALTH CARE; CLINICAL FEATURE; CONTROLLED STUDY; CREAM; DERMATOLOGY; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; ERYTHEMA MULTIFORME; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; INFANT; MALE; PATHOGENESIS; PEDIATRICIAN; PHOTOSENSITIVITY DISORDER; RASH; SERUM SICKNESS; STEVENS JOHNSON SYNDROME; SYMPTOMATOLOGY; TOXIC EPIDERMAL NECROLYSIS; TREATMENT PLANNING; URTICARIA;

EID: 0035194518     PISSN: 00459380     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1538-5442(01)70015-6     Document Type: Article

References (192)

1. Cutaneous drug reactions: Clinical types and causative agents. A five-year survey of inpatients (1981-1985)
2. An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use
3. Intensive monitoring of adverse drug reactions in infants and preschool children
4. Antibiotic rashes in children: A survey in a private practice setting
5. Anticonvulsant hypersensitivity syndrome: Incidence, prevention and management
6. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982
7. Adverse drug reactions. Cutaneous drug reactions: An integral synopsis of today's systemic drugs
8. Drug hypersensitivity reactions and human immunodeficiency virus disease
9. Drug-induced skin reactions in patients with acute non-lymphocytic leukaemia
10. Life-threatening reaction to trimethoprim/sulfamethoxazole in pediatric human immunodeficiency virus infection
11. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome
12. Classification of allergic reactions responsible for clinical hypersensitivity and disease
13. Allergic reactions to drugs and biologic agents
14. Hypersensitivity reactions to antibiotics commonly used in children
15. Allergic reactions to drugs and biological agents
16. Maculopapularism
17. Recent advances in the pathology of cutaneous drug eruptions
18. Urticaria in infants: A study of forty patients
19. Pathogenetic factors in urticaria in children. A clinico-experimental study
20. Urticaria in childhood: Pathogenesis and management
21. Acute urticaria in infancy and early childhood: A prospective study
22. Urticaria
23. Pharmacologic therapy for urticaria
24. Clinical pattern of cutaneous drug eruption among children and adolescents in north India
25. Food hypersensitivity and atopic dermatitis: Pathophysiology, epidemiology, diagnosis, and management
26. Urticaria in children. Retrospective evaluation and follow-up
27. Chronic urticaria in childhood: Natural course and etiology
28. Skin reactions to antibacterial agents in general practice
29. The pathogenesis of chronic idopathic urticaria: New evidence suggests an auto-immune basis and implications for treatment
30. A prospective clinical and immunologic analysis of patients with serum sickness
31. Serum sickness-line reactions from cefaclor in children
32. Serum sickness-like reactions associated with cefprozil therapy
33. Quantitative comparison of adverse reactions to cefaclor vs. amoxicillin in a surveillance study
34. Serum sickness in children after antibiotic exposure: Estimates of occurrence and morbidity in a health maintenance organization population
35. Serum sickness-like reactions to amoxicillin, cefaclor, cephalexin, and trimethoprim-sulfamethoxazole
36. Serum sickness-like reaction with bupropion
37. Serum-sickness-like reaction associated with minocycline therapy in adolescents
38. Doxycycline-induced parotitis
39. Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature
40. Serum sickness-like reactions to cefaclor: Role of hepatic metabolism and individual susceptibility
41. Hypersensitivity reactions to drugs
42. Serum sickness-like reaction to cefaclor: Lack of in vitro cross-reactivity with loracarbef
43. Fixed drug eruptions in children
44. Fixed drug eruption associated with co-trimoxazole
45. Drug related clinical pattern in fixed drug eruption
46. Drugs causing fixed eruptions: A study of 450 cases
47. Ninety-eight fixed drug eruptions with provocation test
48. Laxative-induced dermatitis of the buttocks incorrectly suspected to be abusive burns
49. Mucosal fixed drug eruption
50. Drug related involvement of specific sites in fixed eruptions: A statistical evaluation
51. Drug-specific clincial pattern in fixed drug eruptions
52. Fixed eruption in deeply pigmented subjects: Clinical observations in 350 patients
53. Nonpigmenting fixed drug eruption as a distinctive reactions pattern: Examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline
54. Nonpigmenting solitary fixed drug eruption caused by pseudoephedrine hydrochloride
55. Fixed drug eruptions in children: A series of 23 cases with provocative tests
56. Widespread bullous fixed drug eruption mimicking toxic epidermal necrolysis
57. Topical provocation in 31 cases of fixed drug eruption: Change of causative drugs in 10 years
58. Fixed drug eruption: An immunohistochemical investigation of the acute and healing phase
59. Familial occurrence of fixed drug eruptions
60. Fixed drug eruption in a mother and her son
61. Genetic susceptibility to fixed drug eruption: Evidence for a link with HLA-B22
62. Abnormal responses to ultraviolet radiation: Photosensitivity induced by exogenous agents
63. Clinical spectrum of allergic and pseudoallergic drug reactions
64. Basic principles in photomedicine and photochemistry
65. Phototoxic and photoallergic dermatitis
66. Risk of serious cutanous disorders after intitiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study
67. Familial occurrence of hypersensitivity to phenytoin
68. Cutaneous reactions to aniconvulsants
69. Cholestatic liver dysfunction after long-term phenytoin therapy
70. Anticonvulsant hypersensitivity syndrome
71. Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome
72. Phenytoin hypersensitivity reaction
73. Toxic pustuloderma - A new entity?
74. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme
75. Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy"
76. Phenytoin hypersensitivity: 38 cases
77. Dilantin hypersensitivity: Report of a case of hepatitis with jaundice, pyrexia, and exfoliative dermatitis
78. Anticonvulsant hypersensitivity syndrome
79. Azathioprine hypersensitivity-like reactions - A case report and a review of the literature
80. Fever, hepatitis and acute interstitial nephritis in a patient with rheumatoid arthritis. Concurrent manifestations of azathioprine hypersensitivity
81. Reversible renal failure and myositis caused by phenytoin hypersensitivity
82. Myopathy and hypersensitivity to phenytoin
83. Leukopenia as an unusual component of diphenylhydantoin hypersensitivity. A case with pruritus, rash, fever, lymphadenopathy, but low leukocyte count
84. Phenytoin hypersensitivity [clinical conference]
85. Permanent intrinsic B cell immunodeficiency caused by phenytoin hypersensitivity
86. Hypersenstivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure
87. Cutaneous and immunologic reactions to phenytoin
88. Drug-induced hypothyroidismL the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides
89. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk
90. Hypersensitivity reaction in a child due to lamotrigine
91. Lamotrigine-associated rash: Risk/benefit considerations in adults and children
92. Metronidazole hypersensitivity
93. Idiosyncratic drug reactions: The reactive metabolite syndromes
94. Hypersensitivity reaction to terbinafine
95. Studies on the mechanism of drug sensitization: T-cell-dependent popliteal lymph node reaction to diphenylhydantoin
96. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions
97. Systemic corticosteroids in the phenytoin hypersensitivity syndrome
98. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis
99. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany
100. Erythema multiforme: A critical review of characteristics, diagnostic criteria, and causes
101. Erythema multiforme: A review of its characteristics, diagnostic criteria, and management
102. Erythema multiforme in childhood and early infancy
103. Stevens-Johnson syndrome in children
104. Erythema multiforme: Clinical, histopathologic, and immunologic study
105. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome
106. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children
107. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients
108. Head and neck manifestations of erythema multiforme in children
109. Ocular aftermath of Stevens-Johnson syndrome
110. Toxic epidermal necrolysis in a 6-week-old infant
111. Toxic epidermal necrolysis in early infancy
112. Toxic epidermal necrolysis in children - An update
113. Toxic epidermal necrolysis. A review of 75 cases in children
114. Haematological disturbances and immune mechanisms in toxic epidermal necrolysis
115. Toxic epidermal necrolysis (the scalded skin syndrome): A reappraisal
116. Erythema multiforme exudativum: Distinctive pathological process
117. Lymphocyte subsets and Langerhans cells/indeterminate cells in erythema multiforme
118. Genetic susceptibility to toxic epidermal necrolysis
119. Treatment of toxic epidermal necrolysis. Creteil's experience
120. Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children
121. Erythema multiforme in children. Response to treatment with systemic corticosteroids
122. Plasmapheresis in toxic epidermal necrolysis
123. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis
124. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
125. Erythroderma in children: A clinico-etiological study
126. Neonatal and infantile erythrodermas
127. Multiple-dose activated charcoal in an accidental vancomycin overdose
128. [Bacteriological, pharmacological and clinical comparison between amoxycillin and ceftriaxone in the treatment of 300 purulent meningitis]
129. Neonatal erythroderma: Differential diagnosis and management
130. Petechial eruption after the application of EMLA cream
131. An anaesthesia lidocaine/prilocaine cream (EMLA) for epicutaneous application tested for cutting split skin grafts
132. EMLA cream: An improved local anesthetic. Review of current literature
133. Problèmes cutanés après application d'EMLA chez prematures
134. Vascular effects of a local anesthetic mixture in atopic dermatitis
135. Curettage of molluscum contagiosum in children: Analgesia by topical application of a lidocaine/prilocaine cream (EMLA)
136. A prospective study of acute-onset steroid acne associated with administration of intravenous corticosteroids
137. Induction of acne by topical steroids
138. Acne induced by inhaled corticosteroids
139. Steroid acne in a 14-month-old boy
140. Steroid acne
141. Isoniazid-induced acne and pellagra. Occurence in slow inactivators of isoniazid
142. Acne and hidden iodides
143. The effect of testosterone and anabolic steroids on the skin surface lipids and the population of Propionibacteria acnes in young postpubertal men
144. Acne and anticonvulsants
145. Pomade acne
146. Oil acne: Successful treatment with isotretinoin
147. Successful treatment of lithium-induced acne
148. Erythema nodosum in children: A prospective study
149. Erythema nodosum in children: A study of 27 patients
150. Erythema nodosum
151. Plantar erythema nodosum: Cases in two children
152. Diseases of the dermis and the subcutaneous tissues: Erythema nodosum
153. Erythema nodosum and other forms of panniculitis
154. Erythema nodosum in children
155. Recurrent erythema nodosum associated with echinacea herbal therapy
156. Acne fulminans and erythema nodosum during isotretinoin therapy responding to daspsone
157. Recurrent erythema nodosum of pregnancy
158. Erythema nodosum from oral contraceptives
159. Erythema nodosum, estrogens, and pregnancy
160. Erythema nodosum in children
161. Control of chronic erythema nodosum with naproxen
162. Potassium iodide in erythema nodosum and erythematous dermatoses
163. Naproxen-induced pseudoporphyria: A distinctive photodermatitis
164. Naproxen induced pseudoporphyria in juvenile chronic arthritis
165. Naproxen-induced pseudoporphyria in patients with juvenile rheumatoid arthritis
166. Pseudoporphyria induced by propionic acid derivatives
167. Pseudoporphyria from nonsteroidal anti-inflammatory drugs
168. Phototoxic bullous eruptions due to nalidixic acid
169. Phototoxic blisters from high frusemide dosage
170. Porphyria-like cutaneous changes induced bt tetracycline hydrochloride photosensitization
171. Isotretinoin-associated pseudoporphyria
172. Skin fragility and blistering due to use of sunbeds
173. Pseudoporphyria
174. Pseudoporphyria cutanea tarda: Two case reports o n children receiving peritoneal dialysis and erythropoietin therapy
175. Phototoxicity of nonsteroidal inflammatory drugs
176. Nalidixic acid-induced photosensitivity in mice: A model for pseudoporphyria
177. Propionic acid-derived non-steroidal anti-inflammatory drugs are phototoxic in vitro
178. Nonsteroidal anti-inflammatory-induced pseudoporphyria: Is there an alternative drugs?
179. Acute generalized exanthematous pustulosis (AGEP), an uncommon condition in children: Case report and review of the literature
180. Acute generalized exanthematous pustulosis. Analysis of 63 cases
181. [Acute generalized exanthematic pustuloses (four cases) (author's transl)]
182. Generalized pustular dermatosis caused by isoniazid
183. Acute generalized exantematous pustular dermatitis induced by diltiazem
184. Acute generalized exanthematous pustulosis following oral nystatin therapy: A report of three cases
185. Drug-induced acute generalized exanthematous pustulosis with positive patch tests
186. Pustular eruption following administration of cefazolin: A second case report
187. Pustular eruption following administration of cephradine
188. Pustular dermatosis induced by co-trimoxazole
189. Toxic pustuloderma following carbamazepine therapy
190. Acute generalized exanthematous pustulosis due to doxycycline
191. Lamotrigine-associated rash: Risk/benefit considerations in adults and children